ATE276364T1 - Biologisches material zur herstellung pharmazeutischer zusammensetzungen zur behandlung von säugetieren - Google Patents
Biologisches material zur herstellung pharmazeutischer zusammensetzungen zur behandlung von säugetierenInfo
- Publication number
- ATE276364T1 ATE276364T1 AT99950801T AT99950801T ATE276364T1 AT E276364 T1 ATE276364 T1 AT E276364T1 AT 99950801 T AT99950801 T AT 99950801T AT 99950801 T AT99950801 T AT 99950801T AT E276364 T1 ATE276364 T1 AT E276364T1
- Authority
- AT
- Austria
- Prior art keywords
- gene
- pharmaceutical compositions
- biological material
- cell
- mammals
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9813279A FR2784997A1 (fr) | 1998-10-22 | 1998-10-22 | Materiel biologique pour la preparation de compositions pharmaceutiques destinees au traitement de mammiferes |
| PCT/FR1999/002551 WO2000024896A2 (fr) | 1998-10-22 | 1999-10-20 | Materiel biologique pour la preparation de compositions pharmaceutiques destinees au traitement de mammiferes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE276364T1 true ATE276364T1 (de) | 2004-10-15 |
Family
ID=9531887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99950801T ATE276364T1 (de) | 1998-10-22 | 1999-10-20 | Biologisches material zur herstellung pharmazeutischer zusammensetzungen zur behandlung von säugetieren |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20050221435A1 (de) |
| EP (1) | EP1084246B1 (de) |
| JP (1) | JP2002528466A (de) |
| AT (1) | ATE276364T1 (de) |
| AU (1) | AU754505C (de) |
| CA (1) | CA2344207A1 (de) |
| DE (1) | DE69920216T2 (de) |
| DK (1) | DK1084246T3 (de) |
| ES (1) | ES2228115T3 (de) |
| FR (1) | FR2784997A1 (de) |
| PT (1) | PT1084246E (de) |
| WO (1) | WO2000024896A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040142885A1 (en) * | 2001-01-26 | 2004-07-22 | Stephane Paul | Biological organism for preparing pharmaceutical compositions for treating mammals |
| US7493278B2 (en) * | 2002-09-30 | 2009-02-17 | Goldman Sachs & Co. | Method and system for analyzing a capital structure for a company |
| DE102007001370A1 (de) | 2007-01-09 | 2008-07-10 | Curevac Gmbh | RNA-kodierte Antikörper |
| BR112019017241A2 (pt) | 2017-04-13 | 2020-04-14 | Agenus Inc. | anticorpos anti-cd137 e métodos de uso dos mesmos |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| US12234473B2 (en) | 2020-12-31 | 2025-02-25 | Immatics US, Inc. | CD8 polypeptides, compositions, and methods of using thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA68327C2 (en) * | 1995-07-04 | 2004-08-16 | Gsf Forschungszentrum Fur Unwe | A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals |
| FR2758569B1 (fr) * | 1997-01-20 | 1999-04-02 | Centre Nat Rech Scient | Materiel biologique pour le traitement d'un mammifere par transfert de gene d'anticorps et composition pharmaceutique le concernant |
-
1998
- 1998-10-22 FR FR9813279A patent/FR2784997A1/fr not_active Withdrawn
-
1999
- 1999-10-20 AT AT99950801T patent/ATE276364T1/de not_active IP Right Cessation
- 1999-10-20 DK DK99950801T patent/DK1084246T3/da active
- 1999-10-20 WO PCT/FR1999/002551 patent/WO2000024896A2/fr not_active Ceased
- 1999-10-20 AU AU63444/99A patent/AU754505C/en not_active Ceased
- 1999-10-20 CA CA002344207A patent/CA2344207A1/fr not_active Abandoned
- 1999-10-20 PT PT99950801T patent/PT1084246E/pt unknown
- 1999-10-20 DE DE69920216T patent/DE69920216T2/de not_active Expired - Fee Related
- 1999-10-20 ES ES99950801T patent/ES2228115T3/es not_active Expired - Lifetime
- 1999-10-20 JP JP2000578448A patent/JP2002528466A/ja not_active Withdrawn
- 1999-10-20 EP EP99950801A patent/EP1084246B1/de not_active Expired - Lifetime
-
2005
- 2005-05-09 US US11/124,097 patent/US20050221435A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU6344499A (en) | 2000-05-15 |
| FR2784997A1 (fr) | 2000-04-28 |
| WO2000024896A3 (fr) | 2000-08-03 |
| DE69920216D1 (de) | 2004-10-21 |
| JP2002528466A (ja) | 2002-09-03 |
| DE69920216T2 (de) | 2005-09-22 |
| AU754505B2 (en) | 2002-11-21 |
| CA2344207A1 (fr) | 2000-05-04 |
| EP1084246A2 (de) | 2001-03-21 |
| PT1084246E (pt) | 2005-02-28 |
| AU754505C (en) | 2003-12-04 |
| US20050221435A1 (en) | 2005-10-06 |
| DK1084246T3 (da) | 2005-01-31 |
| WO2000024896A2 (fr) | 2000-05-04 |
| EP1084246B1 (de) | 2004-09-15 |
| ES2228115T3 (es) | 2005-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mülling et al. | How structures in bovine hoof epidermis are influenced by nutritional factors. | |
| AU560340B2 (en) | Rennin from recombinant dna | |
| DE69230993D1 (de) | Rekombinante viren vektoren zur expression in muskelzellen | |
| ES8505724A1 (es) | Procedimiento para la produccion de polipetidos mediante levadura. | |
| ATE296875T1 (de) | Verfahren zur herstellung von genetisch modifizierten cd34-negativen, adhärent wachsenden hämatopoietischen stammzellen | |
| DK720488D0 (da) | Immunokompromitterede kimaerepattedyr og anvendelse heraf til fremstilling af celler og stoffer | |
| ATE352559T1 (de) | Verfahren zur verminderung der immunogenität von proteinen | |
| ATE88500T1 (de) | Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel. | |
| AU754505C (en) | Biological material for preparing pharmaceutical compositions for treating mammals | |
| Mahmoudi et al. | An Elastin‐Derived Composite Matrix for Enhanced Vascularized and Innervated Bone Tissue Reconstruction: From Material Development to Preclinical Evaluation | |
| DE69534633D1 (de) | Implantat und vektor zur behandlung von erworbenen krankheiten | |
| KR970706838A (ko) | 조혈 단백질을 사용한 적혈구생성을 자극하는 방법(methods for stimulating erythropoiesis using hematopoietic proteins) | |
| DE3752391D1 (de) | Rattenproteinkinase C und Verfahren zur Herstellung | |
| Dao et al. | Molecular control of cell cycle progression in primary human hematopoietic stem cells: methods to increase levels of retroviral-mediated transduction | |
| EP0206200A3 (en) | Human cholinesterase-type proteins and their production | |
| DE69837380D1 (de) | Biologisches material zur behandlung eines säugetieres durch transfer einesfür einen antikörper kodierendes gen und eine pharmazeutische zusammensetzungdie diese enthält | |
| DE3877136D1 (de) | Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung. | |
| Edwards et al. | Divergence of β-Myosin Heavy Chain (βMHC) Expression in Fetal Rat Cardiomyocytesin Vitroand Adult Rat Heartin Vivo | |
| ATE260339T1 (de) | Antikörper gegen menschliches restrictin | |
| WO2002059291A3 (fr) | Materiel biologique pour la preparation de compositions pharmaceutiques destinees au traitement de mammiferes | |
| US8323963B2 (en) | Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease | |
| JPH07501695A (ja) | Ifn‐ガンマ‐アンタゴニストサイトカイン | |
| AU5276296A (en) | Medicament containing at least one part of the ul84 protein of the cytomegalovirus, use of polypeptides corresponding to the amino acid sequence of the ul84 protein, and process for introducing ul84 into target cells | |
| Badieyan | Establishing mRNA Delivery Systems for Conversion of Cell Differentiation Status | |
| US20030077758A1 (en) | Myc repressor modulation to treat aging-related disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1084246 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |